[{"country": "United States", "city": "Springerville", "address_1": "105 W Main St", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "1 container", "code_info": "all lots", "center_classification_date": "20151201", "distribution_pattern": "Nationwide in US: Arizona, California, Georgia, New Mexico, South Carolina, South Dakota, Texas, and Utah", "state": "AZ", "product_description": "Heparin Sodium 30,000U/30ML Injection, Rx, Western Drug Inc. 106 E. Main Street, Springerville, Arizona 85938", "report_date": "20151209", "classification": "Class II", "openfda": {}, "recalling_firm": "Western Drug", "recall_number": "D-0430-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "72520", "termination_date": "20161001", "more_code_info": "", "recall_initiation_date": "20151019", "postal_code": "85938-7203", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Pine Brook", "address_1": "26 Chapin Rd", "reason_for_recall": "Presence of Foreign Matter: Guaifenesin API powder is being recalled due to the possibility that the product contains polyethylene fibers from a screen used to sift the Guaifenesin.", "address_2": "Suite 1103", "product_quantity": "30,800 Kg", "code_info": "211J3291  211J3292  211K3293  211K3294  211K3295  211K3297  211K3298  211K3299  211K3301  211K3302  211K3315  211K3321  211K3322", "center_classification_date": "20140318", "distribution_pattern": "Nationwide", "state": "NJ", "product_description": "Guaifenesin USP, 50 Kg Drums, CAS No. 93-14-1, Reg. No. 05436, Caution: For Manufacturing, Processing, or Repacking, Delta Synthetic Co., Ltd. 15, Minsheng St., Tucheng Dist., New Taipei City, 23679, Taiwan (ROC), NDC 60203-1001", "report_date": "20140326", "classification": "Class II", "openfda": {}, "recalling_firm": "Traxx International Corp", "recall_number": "D-1165-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "67661", "termination_date": "20170926", "more_code_info": "", "recall_initiation_date": "20140114", "postal_code": "07058-9210", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78575", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico, China, Chile, Guam, Honduras, India, Israel, Malaysia, Mexico, Turkey", "recall_number": "D-0301-2018", "product_description": "Medline Skin Biopsy Pack-LF, Sterile, Single Use Only. Packaged in USA by Medline Industries, Inc., Northfield, IL 60093", "product_quantity": "120 cases", "reason_for_recall": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.", "recall_initiation_date": "20170921", "center_classification_date": "20180204", "termination_date": "20230828", "report_date": "20180207", "code_info": "Pack Number: DYNJ0394028; Lots 17HK3191", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; MAGNESIUM CHLORIDE DR, Tablet, 64 mg may be potentially mislabeled as    SELEGILINE HCL, Capsule, 5 mg, NDC 67253070006, Pedigree: AD54549_19, EXP: 5/20/2014;  PHOSPHORUS, Tablet, 250 mg, NDC 64980010401, Pedigree: AD70639_10, EXP: 5/29/2014.", "address_2": "", "product_quantity": "180 Tablets", "code_info": "MAGNESIUM CHLORIDE DR, Tablet, 64 mg has the following codes    Pedigree: AD54510_1, EXP: 2/28/2014;  Pedigree: AD70615_1, EXP: 2/28/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "MAGNESIUM CHLORIDE DR, Tablet, 64 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904791152", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-492-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Completed", "city": "Jenison", "state": "MI", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "85854", "recalling_firm": "MICHIGAN HERBAL REMEDIES", "address_1": "904 Chicago Dr", "address_2": "", "postal_code": "49428-9351", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide via internet sales,retailers and distributors in the USA", "recall_number": "D-1479-2020", "product_description": "BC Hemp Co., Full Spectrum Hemp Extract, CBD Oil, Natural, 1000MG CBD, 1 FL. OZ (30 ML) bottles, Distributed by: B.C. Hemp Co., LLC, P.O. Box 156, Eau Claire, MI 49111", "product_quantity": "25 bottles", "reason_for_recall": "Chemical contamination: product contains elevated levels of undeclared lead.", "recall_initiation_date": "20200618", "center_classification_date": "20200804", "report_date": "20200812", "code_info": "FG003318", "more_code_info": ""}, {"status": "Terminated", "city": "Badepalle", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86191", "recalling_firm": "Hetero Labs Limited (Unit V)", "address_1": "458 Surv No 439 - 441", "address_2": "Polepally Village", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to major wholesalers/distributors throughout the United States.", "recall_number": "D-1545-2020", "product_description": "Losartan Potassium Tablets USP, 50 mg, 90 count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ by Hetero Labs, Limited, Mahabubragar, India", "product_quantity": "43,512 bottles", "reason_for_recall": "Failed Tablet/Capsule Specification; complaint of bulging tablet", "recall_initiation_date": "20200806", "center_classification_date": "20200826", "termination_date": "20220124", "report_date": "20200902", "code_info": "Batch # LOA19357A, exp. date 09/2021"}, {"status": "Terminated", "city": "Carmel", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "71952", "recalling_firm": "Silarx Pharmaceutical, Inc.", "address_1": "1033 Stoneleigh Ave", "address_2": "N/A", "postal_code": "10512-2414", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1416-2015", "product_description": "Lamivudine Oral Solution, USP, 10 mg per 1 mL, 240 mL bottle (8 ounces), Rx only, Manufactured by: Silarx Pharmaceuticals, Inc. Carmel, NY 10512, NDC 54838-0566-70", "product_quantity": "576 bottles", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp. Date - Firm received a customer complaint that the expiration date printed on the unit carton (5/18) does not match the expiration date on the bottle label (5/17).", "recall_initiation_date": "20150821", "center_classification_date": "20150903", "termination_date": "20151202", "report_date": "20150909", "code_info": "Lot # 0649A Exp. Date 05/18 (unit carton)"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0531-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Heart Regularity, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955506522, NDC 57955-5065-2", "product_quantity": "478 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot Numbers: 030718F Exp. 03/20; 051716N Exp. 05/19; 080916K Exp. 08/19"}, {"status": "Terminated", "city": "Athens", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83074", "recalling_firm": "RXQ Compounding LLC", "address_1": "340 W State St Unit 9", "address_2": "N/A", "postal_code": "45701-1564", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA", "recall_number": "D-1643-2019", "product_description": "Copper 0.4MG/ML (PVF) INJECTION SOLUTION, 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701.  NDC: 70731-0925-10", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190619", "center_classification_date": "20190808", "termination_date": "20220916", "report_date": "20190814", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA200816"], "brand_name": ["LANSOPRAZOLE"], "generic_name": ["LANSOPRAZOLE"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "product_ndc": ["68382-771", "68382-772"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LANSOPRAZOLE"], "rxcui": ["351260", "351261"], "spl_id": ["3de4f129-dc87-48e1-b934-b2a038df8cf7"], "spl_set_id": ["9b3869ad-f2f7-4954-b75c-5c23b8951635"], "package_ndc": ["68382-771-30", "68382-771-77", "68382-772-30", "68382-772-77"], "is_original_packager": [true], "nui": ["N0000175525", "N0000000147", "N0000009724"], "pharm_class_epc": ["Proton Pump Inhibitor [EPC]"], "pharm_class_moa": ["Proton Pump Inhibitors [MoA]"], "pharm_class_pe": ["Inhibition Gastric Acid Secretion [PE]"], "unii": ["0K5C5T2QPG"]}, "product_type": "Drugs", "event_id": "86663", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0075-2021", "product_description": "Lansoprazole Delayed-Release Orally Disintegrating Tablets 30 mg, 100-count carton (10 x10 unit-dose), Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534, NDC 68382-772-77", "product_quantity": "7,908 units", "reason_for_recall": "Failed Dissolution Specification", "recall_initiation_date": "20201027", "center_classification_date": "20201110", "termination_date": "20221220", "report_date": "20201111", "code_info": "Lot # M005682, EXP 3/2022"}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA018016"], "brand_name": ["SODIUM CHLORIDE"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["0338-0043", "0338-0049"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["1807551", "1807552", "1807627", "1807630", "1807631", "1807632", "1807633", "1807634", "1807639"], "spl_id": ["6ab23768-efd2-4ff1-b336-0dda08dc56e1"], "spl_set_id": ["f55bd888-5e01-474d-871b-24654c070178"], "package_ndc": ["0338-0049-01", "0338-0049-02", "0338-0049-03", "0338-0049-04", "0338-0049-10", "0338-0049-41", "0338-0049-11", "0338-0049-31", "0338-0049-48", "0338-0049-18", "0338-0049-38", "0338-0043-03", "0338-0043-04"], "is_original_packager": [true], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "83340", "recalling_firm": "Baxter Healthcare Corporation", "address_1": "1 Baxter Pkwy", "address_2": "N/A", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the United States and Puerto Rico.", "recall_number": "D-1514-2019", "product_description": "0.9% Sodium Chloride Injection USP, 100 mL Viaflex Container, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-0049-38.", "product_quantity": "139,680 Containers", "reason_for_recall": "Lack of Assurance of Sterility: Bags have potential to leak.", "recall_initiation_date": "20190718", "center_classification_date": "20190723", "termination_date": "20210419", "report_date": "20190731", "code_info": "Lot #s: P389684; P389742, Exp. 8/31/2020"}, {"status": "Terminated", "city": "Overland Park", "state": "KS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69674", "recalling_firm": "Perry Drug Inc.", "address_1": "12200 W 106th St Ste 140", "address_2": "N/A", "postal_code": "66215-2305", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Kansas and Missouri", "recall_number": "D-0270-2015", "product_description": "2Ml HCG 10,000 U/ MB12 - 12,000 MCG/10 Ml Inj, 0.25ML (250IU), Rx, Perry Drug Compounding Pharmacy, Overland Park, KS ---NDC 88888-7945-17", "product_quantity": "1 vial", "reason_for_recall": "Lack of sterility assurance;All lots of sterile products compounded by the pharmacy that are within expiry were recalled due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141107", "center_classification_date": "20141124", "termination_date": "20151103", "report_date": "20141203", "code_info": "141016A, 11/16/14", "more_code_info": ""}, {"status": "Ongoing", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202910"], "brand_name": ["IRBESARTAN"], "generic_name": ["IRBESARTAN"], "manufacturer_name": ["AvPAK"], "product_ndc": ["50268-441", "50268-440", "50268-442"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["IRBESARTAN"], "rxcui": ["200094", "200095", "200096"], "spl_id": ["3c1c8771-3bbc-7b5a-e063-6394a90a192c"], "spl_set_id": ["61b60f94-35e6-b90b-08ce-fbb2fe011f34"], "package_ndc": ["50268-440-11", "50268-440-15", "50268-441-11", "50268-441-15", "50268-442-11", "50268-442-15"], "original_packager_product_ndc": ["31722-729", "31722-730", "31722-731"], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["J0E2756Z7N"]}, "product_type": "Drugs", "event_id": "96172", "recalling_firm": "AvKARE", "address_1": "615 N 1st St", "address_2": "", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0224-2025", "product_description": "Irbesartan Tablets USP, 300 mg, 50 Tablets (5 x 10) Unit Dose per carton, Manufactured for: AvKARE, Pulaski, TN 38478. NDC 50268-442-15", "product_quantity": "341 cartons", "reason_for_recall": "Out of Specification for Dissolution", "recall_initiation_date": "20250121", "center_classification_date": "20250211", "report_date": "20250219", "code_info": "Lot 45279, Exp 03/31/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Concord", "state": "NC", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "63127", "recalling_firm": "McKesson Packaging Services", "address_1": "7101 Weddington Rd NW", "address_2": "N/A", "postal_code": "28027-3412", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-001-2013", "product_description": "buPROPion Hydrochloride Extended-Release Tablets (XL), 150 mg, UD 100 Tablets (10 x 10) per carton, Rx only, Mfg By: CMIC-VPS Corporation, Cranbury, New Jersey  08512; blister barcode N (01)003 63739 449 10 7, Dist By: McKesson Packaging, Concord, NC  28027; NDC 63739-449-10, carton barcode 6373944910.", "product_quantity": "187 cartons", "reason_for_recall": "Failed USP Dissolution Test Requirements: Possible out-of-specification dissolution results at the 8 hour stability testing point.", "recall_initiation_date": "20120329", "center_classification_date": "20121001", "termination_date": "20130411", "report_date": "20121010", "code_info": "Lot #: 0074583, Exp. Date 03/12"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: ACARBOSE, Tablet, 25 mg may be potentially mislabeled as one of the following drugs:  ZINC GLUCONATE, Tablet, 50 mg, NDC 00904319160, Pedigree: AD60240_57, EXP: 5/22/2014;  TOLTERODINE TARTRATE ER, Capsule, 2 mg, NDC 00009519001, Pedigree: W002724, EXP: 6/6/2014;  SILDENAFIL CITRATE, Tablet, 25 mg, NDC 00069420030, Pedigree: W003646, EXP: 6/25/2014;  SEVELAMER CARBONATE, Tab", "address_2": "", "product_quantity": "399 Tablets", "code_info": "ACARBOSE, Tablet, 25 mg has the following codes:   Pedigree: AD60272_1, EXP: 5/22/2014;  Pedigree: W002725, EXP: 6/6/2014;  Pedigree: W003673, EXP: 6/25/2014;  Pedigree: W002996, EXP: 6/11/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ACARBOSE, Tablet, 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00054014025.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-795-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Tarrytown", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83417", "recalling_firm": "Medtech Products, Inc.", "address_1": "660 White Plains Rd Ste 250", "address_2": "N/A", "postal_code": "10591-5171", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico, St. Michael, Barbados, Guyana, St. Johns, Antigua and Barbuda, Kingston 5, and Jamaica.", "recall_number": "D-1825-2019", "product_description": "Clear eyes MAXIMUM REDNESS RELIEF (Glycerin 0.5%, Naphazoline hydrochloride 0.03%) eye drops, 0.5 FL OZ (15 mL) bottle, Distributed by Medtech Products Inc., Tarrytown, NY  10591, A Prestige Brands Company, UPC 6 78112 66577 8.", "product_quantity": "1,872,984 bottles", "reason_for_recall": "CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.", "recall_initiation_date": "20190726", "center_classification_date": "20190816", "termination_date": "20210310", "report_date": "20190828", "code_info": "Lot #: 16234, 16247, Exp 08/19; 16286, Exp 10/19; 16314, Exp 11/19"}, {"status": "Terminated", "city": "Salem", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83538", "recalling_firm": "Ridge Properties, LLC", "address_1": "4995 Ridge Dr NE", "address_2": "N/A", "postal_code": "97301-7475", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA via internet sales through Amazon.com; ebay.com; Walmart.com; tatbalm.net; Naturallyhl.com", "recall_number": "D-1860-2019", "product_description": "Soothing Sore Relief (lidocaine) Cream, 4%, packaged in a) 1 OZ (NDC 69804-074-05), b) 2 OZ (NDC 69804-074-02), and c) 4 OZ (NDC 69804-074-03) jars, OTC, Manufactured, packed & distributed by Pain Relief Naturally, Salem, OR 97301.", "product_quantity": "136 ounces", "reason_for_recall": "Superpotent Drug: products were found to be contaminated and above specification for lidocaine assay.", "recall_initiation_date": "20190809", "center_classification_date": "20190913", "termination_date": "20230712", "report_date": "20190925", "code_info": "Lot # 1228, Exp 06/21/2023"}, {"status": "Terminated", "city": "Bristol", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82554", "recalling_firm": "Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy", "address_1": "Attn: Cleve Anderson", "address_2": "310 Bluff City Hwy", "postal_code": "37620-4602", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1165-2019", "product_description": "Penicillin G 100,000/mL 10 mL Syringe, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.", "product_quantity": "1 vial", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190402", "center_classification_date": "20190418", "termination_date": "20210924", "report_date": "20190424", "code_info": "All Lots"}, {"country": "United States", "city": "North Wales", "address_1": "1090 Horsham Rd", "reason_for_recall": "Failed Impurities and Degradation Specifications and Subpotent Drug: out-of-specification (OOS) test results for below assay and above specification for degradants.", "address_2": "", "product_quantity": "27,803 bottles", "code_info": "Lot #s: 1164898, EXP 10/18; 1164904, 1164909, EXP 11/18; 1211396, EXP 07/19; 1230808, 1231127, EXP 01/20", "center_classification_date": "20180706", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "state": "PA", "product_description": "Fluocinolone Acetonide Topical Solution, USP, 0.01%, 60 mL  bottle, Rx Only, Manufactured by: Actavis Laboratories UT, Inc., Salt Lake City, UT  84108 USA; Distributed by: Actavis Pharmac, Inc., Parsippany, NJ  07054 USA, NDC 0591-2990-60.", "report_date": "20180718", "classification": "Class II", "openfda": {"application_number": ["ANDA208386"], "brand_name": ["FLUOCINOLONE ACETONIDE TOPICAL"], "generic_name": ["FLUOCINOLONE ACETONIDE TOPICAL"], "manufacturer_name": ["Actavis Pharma, Inc."], "product_ndc": ["0591-2990"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["FLUOCINOLONE ACETONIDE"], "rxcui": ["1191310"], "spl_id": ["8c1b96a1-47e6-4fac-9bda-0b299ac25800"], "spl_set_id": ["98dfd7a4-2208-4637-acf5-080a5813a433"], "package_ndc": ["0591-2990-60"], "is_original_packager": [true], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["0CD5FD6S2M"]}, "recalling_firm": "Teva Pharmaceuticals USA", "recall_number": "D-0909-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "80437", "termination_date": "20190403", "more_code_info": "", "recall_initiation_date": "20180705", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Birmingham", "address_1": "6801 Cahaba Valley Rd Ste 116", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "1000 mL in Vials", "code_info": "Lot #: 151228-28, BUD: 06/25/16", "center_classification_date": "20160708", "distribution_pattern": "U.S. Nationwide, Japan, and New Zealand.", "state": "AL", "product_description": "B-COMPLEX #3 (PF), B1-100MG, B2-2-PO4-2MG, B3-100MG, B5-2MG, B6-2MG/ML, 2ML Vials, MEDAUS PHARMACY", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Medaus, Inc.", "recall_number": "D-1167-2016", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "74466", "termination_date": "20170616", "more_code_info": "", "recall_initiation_date": "20160513", "postal_code": "35242-9609", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0986-2023", "product_description": "oxyTOCIN 30 units added to 0.9% sodium chloride 500 mL, IV Bag, Rx only, This drug was repacked by CAPS, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-6044-1", "product_quantity": "130,250 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-238820, 36-238821, 36-238822, 36-238824, 36-238825, Exp. 7/10/2023; 36-239686, 36-239687, 36-239688, 36-239689, 36-239690, 36-239691, 36-239692, 36-239693, 36-239696, 36-239697, 36-239699, 36-239700, Exp. 7/12/2023; 36-239915, 36-239916, 36-239917, 36-239918, 36-239919, 36-239922, 36-239923, Exp. 7/13/2023; 36-240165, 36-240168, 36-240170, 36-240171, 36-240173, 36-240174, Exp. 7/16/2023; 36-240260, 36-240261, 36-240262, Exp. 7/17/2023; 36-240823, 36-240824, 36-240826, 36-240827, 36-240828, 36-240829, 36-240830, 36-240831, 36-240832, 36-240833, 36-240834, Exp. 7/18/2023; 36-241141, 36-241142, 36-241143, 36-241144, 36-241145, 36-241146, 36-241439, Exp. 7/19/2023; 36-241511, 36-241515, 36-241517, 36-241518, 36-241523, 36-241526, 36-241528, Exp. 7/20/2023; 36-241671, 36-241672, 36-241673, 36-241675, 36-241677, 36-241679, 36-241682, 36-241684, 36-241689, Exp. 7/21/2023; 36-241824, 36-241826, 36-241827, 36-241828, 36-241829, 36-241830, 36-241833, 36-241835, 36-241837, 36-241839, 36-241841, 36-241843, 36-241844, 36-241845, 36-241846, Exp. 7/23/2023; 36-241998, 36-242000, 36-242002, 36-242005, 36-242009, 36-242026, 36-242037, 36-242040, 36-242209, 36-242208, Exp. 7/24/2023; 36-242421, 36-242427, 36-242431, 36-242442, 36-242447, 36-242456, 36-242464, 36-242465, Exp. 7/25/2023; 36-242708, 36-242712, 36-243054, Exp. 7/26/2023; 36-243154, 36-243158, 36-243160, 36-243175, 36-243204, 36-243647, 36-243648, Exp. 7/27/2023; 36-243548, 36-243549, Exp. 7/30/2023; 36-243840, 36-243841, Exp. 7/31/2023; 36-245111, 36-245014, 36-245015, 36-245109, 36-245110, 36-245113, 36-245114, 36-245116, Exp. 8/1/2023; 36-245569, 36-245570, 36-245573, 36-245575, 36-246366, 36-246367, Exp. 8/2/2023; 36-246226, 36-246229, 36-246237, 36-246251, 36-246617, 36-246643, Exp. 8/3/2023; 36-246594, 36-246595, 36-246596, 36-246597, 36-246612, 36-246613, 36-246614, 36-246616, 36-246681, 36-246683, 36-246684, 36-246685, 36-246686, 36-246687, 36-246689, Exp. 8/6/2023; 36-246842, 36-246847, 36-246848, 36-246849, 36-246850, 36-246853, 36-246855, 36-246881, Exp. 8/7/2023; 36-247243, 36-247245, 36-247246, 36-247248, 36-247249, 36-247250, 36-247251, 36-247252, 36-247253, Exp. 8/8/2023; 36-247600, 36-247601, 36-247602, 36-247603, 36-247604, 36-247606, 36-247692, 36-247694, 36-247695, 36-247696, 36-247697, 36-247698, 36-247699, Exp. 8/9/2023; 36-248365, 36-248366, Exp. 8/11/2023; 36-248212, 36-248231, 36-248236, 36-248238, 36-248240, 36-248241, 36-248243, Exp. 8/13/2023; 36-248510, 36-248515, 36-248518, Exp. 8/14/2023; 36-248729, 36-248730, 36-248872, 36-248873, 36-248875, 36-248878, 36-248879, 36-248876, Exp. 8/15/2023; 36-248949, 36-248952, 36-248953, 36-248954, 36-248955, 36-248957, 36-248959, 36-248967, 36-248968, 36-248969, 36-248970, Exp. 8/16/2023; 36-249326, 36-249327, 36-249328, 36-249329, 36-249330, 36-249331, 36-249332, 36-249333, 36-249334, 36-249335, 36-249336, 36-249337, 36-249338, Exp. 8/17/2023; 36-249666, 36-249667, 36-249668, 36-249670, Exp. 8/20/2023; 36-249725, 36-249726, 36-249729, 36-249730, 36-249731, 36-249732, 36-249733, 36-249734, 36-249735, 36-249740, Exp. 8/21/2023; 36-249989, 36-249990, 36-249994, 36-250229, 36-250423, Exp. 8/22/2023; 36-250430, 36-250431, 36-250432, 36-250434, 36-250436, 36-250437, 36-250968, 36-250969, 36-250970, 36-250971, 36-250972, 36-250973, 36-250974, 36-250975, Exp. 8/23/2023;  36-251032, 36-251033, 36-251034, 36-251035, 36-251036, 36-251037, 36-251038, 36-251039, 36-251040, 36-251041, 36-251042, 36-251044, 36-251045, Exp. 8/24/2023; 36-251414, 36-251415, 36-251417, 36-251418, 36-251419, 36-251420, 36-251421, 36-251422, 36-251423, 36-251424, 36-251425, 36-251426, 36-251427, 36-251428, 36-251429, 36-251430, Exp. 8/28/2023; 36-251729, 36-251731, 36-251754, 36-251755, 36-251756, 36-251757, 36-251759, 36-251760, 36-251761, 36-251762, 36-251763, 36-251764, 36-251758, Exp. 8/29/2023; 36-251945, 36-251952, 36-251959, 36-251963, 36-251967, 36-251970, 36-251978, 36-251983, 36-251977, Exp. 8/30/2023; 36-254467, 36-254474, 36-254482, 36-254499, 36-254503, 36-254508, 36-254511, 36-254516, 36-254520, 36-254524, 36-255281, Exp. 9/5/2023; 36-254930, 36-254931, 36-254932, 36-254933, 36-254934, 36-254935, 36-254936, Exp. 9/6/2023; 36-255615, Exp. 9/7/2023"}, {"status": "Terminated", "city": "Lindon", "state": "UT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80119", "recalling_firm": "MBi Distributing Inc. dba MBi Nutraceuticals", "address_1": "211 N 1800 W", "address_2": "N/A", "postal_code": "84042-1627", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0867-2018", "product_description": "Teething Drops, Homeopathic Drops for Temporary Relief of Pain Caused by Teething, 1 Fl Ounce glass amber bottle with glass dropper,  MBi Nutraceuticals, Lindon, UT 84042. Bar Code: 3 58301 04011 0", "product_quantity": "121 bottles", "reason_for_recall": "Lack of Processing Controls: Firm is voluntarily recalling all lots of homeopathic Teething Drops, Nausea Drops, Intestinal Colic Drops, Stomach Calm, Expectorant Cough Syrup, Silver-Zinc Throat Spray, and Argentum Elixir, within expiry, due to lack of adequate controls during manufacturing.", "recall_initiation_date": "20180515", "center_classification_date": "20180614", "termination_date": "20200123", "report_date": "20180620", "code_info": "Lot: 15041402, No EXP date"}, {"country": "United States", "city": "Lake Mary", "address_1": "550 Technology Park Ste 1008", "reason_for_recall": "Lack of Assurance of Sterility:All sterile products compounded, repackaged, and distributed by this  compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "", "product_quantity": "", "code_info": "ALL Lots", "center_classification_date": "20130423", "distribution_pattern": "CO, GA, MI, and Puerto Rico", "state": "FL", "product_description": "BiMix Standard Injectable  Balanced Solutions, Compounding Pharmacy a division of Axium Healthcare Pharmacy, Inc., Lake Mary, FL 32746", "report_date": "20130501", "classification": "Class II", "openfda": {}, "recalling_firm": "Axium Healthcare Pharmacy dba Balanced Solutions Compounding", "recall_number": "D-283-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "64957", "termination_date": "20170419", "more_code_info": "", "recall_initiation_date": "20130417", "postal_code": "32746-7131", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Northbrook", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA204096"], "brand_name": ["ASTAGRAF XL"], "generic_name": ["TACROLIMUS EXTENDED-RELEASE CAPSULES"], "manufacturer_name": ["Astellas Pharma US, Inc."], "product_ndc": ["0469-0647", "0469-0677", "0469-0687"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TACROLIMUS"], "rxcui": ["1431971", "1431977", "1431980", "1431982", "1431985", "1431987"], "spl_id": ["15be9383-263f-4080-bda4-2ab0bdfbf239"], "spl_set_id": ["550a5cd4-fbf2-4c09-b577-6bde8fcbdf6e"], "package_ndc": ["0469-0647-73", "0469-0647-11", "0469-0677-73", "0469-0677-11", "0469-0687-73", "0469-0687-11"], "is_original_packager": [true], "unii": ["WM0HAQ4WNM"]}, "product_type": "Drugs", "event_id": "96008", "recalling_firm": "Astellas Pharma US Inc.", "address_1": "2375 Waterview Dr", "address_2": "", "postal_code": "60062-6145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0210-2025", "product_description": "Astagraf XL (tacrolimus extended-release capsules) 0.5 mg, 30-count bottles, RX Only, Product of Japan, Distributed by: Astellas Pharma US Inc., Northbrook, IL 60062, NDC 0469-0647-73.", "product_quantity": "3,500 30-count bottles", "reason_for_recall": "Failed Tablet/Capsule Specifications: Bottles shipped to the USA may contain empty capsules", "recall_initiation_date": "20241223", "center_classification_date": "20250129", "report_date": "20250205", "code_info": "Lot# 0R3092A, EXP 03/31/2026", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Zurich", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA208129"], "brand_name": ["DEXMEDETOMIDINE HYDROCHLORIDE"], "generic_name": ["DEXMEDETOMIDINE HYDROCHLORIDE"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "product_ndc": ["63323-671"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["DEXMEDETOMIDINE HYDROCHLORIDE"], "rxcui": ["1718900", "1718906", "1718909"], "spl_id": ["27411591-44a1-44c4-89c3-dd8c2687f0e2"], "spl_set_id": ["4d5d2294-89a0-4b6f-aa00-d39a0393b6a8"], "package_ndc": ["63323-671-02", "63323-671-20", "63323-671-05", "63323-671-50", "63323-671-01", "63323-671-00"], "is_original_packager": [true], "upc": ["0363323671020", "0363323671051"], "unii": ["1018WH7F9I"]}, "product_type": "Drugs", "event_id": "86766", "recalling_firm": "Fresenius Kabi USA, LLC", "address_1": "3 Corporate Dr", "address_2": "N/A", "postal_code": "60047-8930", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0120-2021", "product_description": "Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg / 50 mL (4 mcg / mL), 50 mL Single Dose Bottle, Rx only, Fresenius Kabi, Lake Zurich, IL 60047, NDC 63323-671-05", "product_quantity": "13,525 bottles", "reason_for_recall": "Cross Contamination with other products: trace amounts of lidocaine", "recall_initiation_date": "20201117", "center_classification_date": "20201208", "termination_date": "20220912", "report_date": "20201216", "code_info": "Lot #: 6123925"}, {"status": "Ongoing", "city": "Piscataway", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202882"], "brand_name": ["PANTOPRAZOLE SODIUM"], "generic_name": ["PANTOPRAZOLE"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "product_ndc": ["31722-712", "31722-713"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PANTOPRAZOLE SODIUM"], "rxcui": ["251872", "314200"], "spl_id": ["10628fbe-c4fa-155d-e063-6394a90af0cb"], "spl_set_id": ["9daa1483-5a36-44db-9e0d-904d100da262"], "package_ndc": ["31722-712-90", "31722-712-32", "31722-712-31", "31722-713-90", "31722-713-32", "31722-713-31", "31722-713-10"], "is_original_packager": [true], "upc": ["0331722713900", "0331722712903"], "unii": ["6871619Q5X"]}, "product_type": "Drugs", "event_id": "91855", "recalling_firm": "Hetero USA Inc", "address_1": "1035 Centennial Ave", "address_2": "N/A", "postal_code": "08854-4124", "voluntary_mandated": "N/A", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0530-2023", "product_description": "Pantoprazole Sodium Delayed Release Tablets USP 40mg, 1000-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals Inc., Piscataway, NJ, 08854, By: Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahabubnagar- 509 301, India NDC 31722-713-10", "product_quantity": "2,352 bottles", "reason_for_recall": "CGMP Deviations: Discoloration", "recall_initiation_date": "20230314", "center_classification_date": "20230411", "report_date": "20230419", "code_info": "Lot #: PAN22542, Exp. Date: 9/2024"}, {"status": "Ongoing", "city": "Bengaluru", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA209101"], "brand_name": ["HALOPERIDOL DECANOATE"], "generic_name": ["HALOPERIDOL DECANOATE"], "manufacturer_name": ["BluePoint Laboratories"], "product_ndc": ["68001-578", "68001-579", "68001-580", "68001-581", "68001-582"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["HALOPERIDOL DECANOATE"], "rxcui": ["859871", "1719803", "1719862"], "spl_id": ["048557ea-f859-f0f2-e063-6294a90af5ab"], "spl_set_id": ["f2d14406-2ad4-4c5b-9c24-a026f27b415d"], "package_ndc": ["68001-579-59", "68001-579-48", "68001-580-41", "68001-581-41", "68001-581-48", "68001-581-82", "68001-578-59", "68001-578-48", "68001-582-41"], "is_original_packager": [true], "upc": ["0368001578592", "0368001581417", "0368001579599", "0368001582414"], "unii": ["AC20PJ4101"]}, "product_type": "Drugs", "event_id": "96569", "recalling_firm": "Somerset Therapeutics Private Limited", "address_1": "54/1 Budihal Village", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0357-2025", "product_description": "Haloperidol Decanoate Injection 100mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured by: Somerset Therapeutics Limited, Kamataka, India, Manufactured for: BluePoint Laboratories  NDC 68001-581-41 (individual carton) and NDC 68001-581-48 (5x1 mL cartons)", "product_quantity": "23,960 vials", "reason_for_recall": "Lack of Assurance of Sterility: Media fill with bacterial contamination", "recall_initiation_date": "20250321", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "NDC 68001-581-41; A240482A, exp. date 08/2026;  NDC 68001-581-48; A240482B, exp. date 08/2026"}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "60 units", "code_info": "Rx # 29082 Exp. 5/19/14", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "Unasyn (ampicillin/sulbactam) 1.5 gm/100 mL 0.9%NS, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 29082, Discard After 05/19/14", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1463-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Ongoing", "city": "Rockford", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076187"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Mylan Institutional Inc."], "product_ndc": ["51079-440", "51079-444", "51079-441", "51079-442", "51079-443", "51079-445"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "966220", "966221", "966222", "966224", "966225"], "spl_id": ["3a864332-4c4d-08a5-e063-6294a90aaaff"], "spl_set_id": ["5723c7a7-2a1d-4ab6-bf39-b2165ae781a6"], "package_ndc": ["51079-440-01", "51079-440-20", "51079-444-01", "51079-444-20", "51079-441-01", "51079-441-20", "51079-442-01", "51079-442-20", "51079-443-01", "51079-443-20", "51079-445-01", "51079-445-20"], "original_packager_product_ndc": ["0378-1803", "0378-1800", "0378-1805", "0378-1809", "0378-1813", "0378-1815"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "96428", "recalling_firm": "Mylan Institutional, Inc.", "address_1": "1718 Northrock Ct", "address_2": "N/A", "postal_code": "61103-1201", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0290-2025", "product_description": "Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), Rx Only, 100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each) per carton, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in India, NDC 51079-445-20.", "product_quantity": "347 Cartons", "reason_for_recall": "Super-Potent Drug: Out of specification potency results were obtained.", "recall_initiation_date": "20250307", "center_classification_date": "20250320", "report_date": "20250326", "code_info": "Lot 3116074, Exp. 09/30/2025"}, {"country": "United States", "city": "Orlando", "address_1": "6700 Conroy Windermere Rd", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "address_2": "Suite 140", "product_quantity": "1", "code_info": "C51212 Exp 8/12/13", "center_classification_date": "20130711", "distribution_pattern": "Nationwide and PR", "state": "FL", "product_description": "Estradiol Cypionate 2 mg/ml Test Cyp 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL", "report_date": "20130717", "classification": "Class II", "openfda": {}, "recalling_firm": "Lowlite Investments, Inc. D/B/A Olympia Pharmacy", "recall_number": "D-728-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "65360", "recall_initiation_date": "20130529", "postal_code": "32835-3500", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Ongoing", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090778"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["57237-017", "57237-018", "57237-019"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934"], "spl_id": ["4166006e-ead3-4e01-8b11-07d26ac957ed"], "spl_set_id": ["ea2dc1a6-22d5-4295-9d39-9bf015dc5a89"], "package_ndc": ["57237-017-60", "57237-017-99", "57237-018-30", "57237-018-90", "57237-018-99", "57237-019-30", "57237-019-90", "57237-019-99"], "is_original_packager": [true], "upc": ["0357237018309", "0357237017609", "0357237019306"], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "96074", "recalling_firm": "Rising Pharma Holding, Inc.", "address_1": "2 Tower Center Blvd Ste 1401", "address_2": "", "postal_code": "08816-1149", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0189-2025", "product_description": "Duloxetine Delayed-Release Capsules USP 20 mg, 60 count bottles, Rx only, Distributed by: Rising Pharm Holdings, Inc., East Brunswick, NJ NDC 57237-017-60", "product_quantity": "73,680 bottles", "reason_for_recall": "CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.", "recall_initiation_date": "20241230", "center_classification_date": "20250108", "report_date": "20250115", "code_info": "Lot # DT2023003A, DT2023007A, DT2023008A, exp. date Jan-25", "more_code_info": ""}, {"status": "Terminated", "city": "Cary", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82993", "recalling_firm": "Chiesi USA, Inc.", "address_1": "175 Regency Woods Place, Ste. 600", "address_2": "N/A", "postal_code": "27518-8128", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-1341-2019", "product_description": "ZYFLO CR (zileuton) extended-release tablets, 600 mg, 120-count bottles, Rx only, Distributed by Chiesi USA, Inc., Cary, NC 27518, NDC 10122-902-12.", "product_quantity": "2118 bottles", "reason_for_recall": "Failed Dissolution Specifications: Out of specification result for dissolution.", "recall_initiation_date": "20190531", "center_classification_date": "20190613", "termination_date": "20210308", "report_date": "20190619", "code_info": "Lots: 3171855, Exp. 12/19"}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "12 units", "code_info": "Rx # 29157, Exp 5/19/14; Rx # 29097, Exp 5/20/14", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "Invanz  (ertapenem)1 gm/100 mL 0.9%NS, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 29157, Discard After 05/19/14; Rx # 29097, Discard After 05/20/14", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1460-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076784"], "brand_name": ["TRI-LO-SPRINTEC"], "generic_name": ["NORGESTIMATE AND ETHINYL ESTRADIOL"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0093-2140"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "rxcui": ["578732", "748797", "749155", "749156", "749157", "856467"], "spl_id": ["204ad27b-376e-4d07-bf27-1db57f446045"], "spl_set_id": ["ddbeb312-af2b-4d22-ab7c-5ab2f3f8d5cb"], "package_ndc": ["0093-2140-28", "0093-2140-62"], "is_original_packager": [true]}, "product_type": "Drugs", "event_id": "94183", "recalling_firm": "Teva Pharmaceuticals USA, Inc", "address_1": "400 Interpace Pkwy Bldg A", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0428-2024", "product_description": "Tri-Lo-Sprintec (norgestimate and ethinyl estradiol) tablets USP - triphasic regimen, packaged in carton containing 3 Blister Cards, 28 Tablets Each, Rx only, Teva Pharmaceuticals USA, INC, North Wales, PA 19454, NDC 0093-2140-62", "product_quantity": "92,676 cartons", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20240307", "center_classification_date": "20240328", "termination_date": "20250306", "report_date": "20240403", "code_info": "Lot # 100039678, Exp 04/31/2024; 100038111, 100042277, Exp 07/31/2024", "more_code_info": ""}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0105-2022", "product_description": "ALPROSTADIL 45MCG/ML  45MCG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "2 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 06112021:61 BUD: 10/09/2021", "more_code_info": ""}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx #:  0398938", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "RUBIDIUM 200MCG/ML INJECTABLE\t30 ML  (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1614-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078181"], "brand_name": ["GLIMEPIRIDE"], "generic_name": ["GLIMEPIRIDE"], "manufacturer_name": ["Accord Healthcare Inc"], "product_ndc": ["16729-001", "16729-002", "16729-003"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["GLIMEPIRIDE"], "rxcui": ["199245", "199246", "199247"], "spl_id": ["415deb6c-47dc-ed2a-e063-6394a90a66fa"], "spl_set_id": ["9b74fbac-9e04-4927-9981-1e3dace89c6d"], "package_ndc": ["16729-001-01", "16729-001-16", "16729-001-17", "16729-002-01", "16729-002-16", "16729-002-17", "16729-003-01", "16729-003-16", "16729-003-17"], "is_original_packager": [true], "upc": ["0316729003018", "0316729002011", "316729003018", "316729003162"], "nui": ["N0000175608", "M0020795"], "pharm_class_epc": ["Sulfonylurea [EPC]"], "pharm_class_cs": ["Sulfonylurea Compounds [CS]"], "unii": ["6KY687524K"]}, "product_type": "Drugs", "event_id": "91657", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and Canada", "recall_number": "D-0395-2023", "product_description": "Glimepiride Tablets USP, 4 mg, Rx Only, Packaged in: a) 100-count bottle NDC 16729-003-01 UPC 3 16729 00301 8; b) 500-count NDC 16729-003-16 UPC 3 16729 00316 2; Manufactured for: Accord Healthcare, Inc., Durham, NC 27703. Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, INDIA", "product_quantity": "1,158,839 bottles", "reason_for_recall": "CGMP Deviations: recalling drug products following an FDA inspection.", "recall_initiation_date": "20230207", "center_classification_date": "20230302", "termination_date": "20240422", "report_date": "20230308", "code_info": "Batches: a) P2001868, Exp. Date 3/31/2023, P2001869 Exp. Date 3/31/2023, P2002810 Exp. Date 5/31/2023, P2005473 Exp. Date 8/31/2023, P2005552 Exp. Date 9/30/2023, P2101986 Exp. Date 3/31/2024, P2101989 Exp. Date 3/31/2024, P2101988 Exp. Date 3/31/2024, P2101991 Exp. Date 3/31/2024, P2101992 Exp. Date 3/31/2024, R2100736 Exp. Date 6/30/2024, R2100737 Exp. Date 6/30/2024, P2105281 Exp. Date 7/31/2024, R2101441 Exp. Date 9/30/2024, R2101454 Exp. Date 10/31/2024, R2101455 Exp. Date 10/31/2024, R2101468 Exp. Date 10/31/2024, R2101469 Exp. Date 10/31/2024, R2200096 Exp. Date 12/31/2024; b)P2005550, Exp. Date 9/30/2023, P2005549 Exp. Date 9/30/2023, P2005551 Exp. Date 9/30/2023, P2005812 Exp. Date 10/31/2023, P2005813 Exp. Date 10/31/2023, P2005970 Exp. Date 10/31/2023, P2005971 Exp. Date 10/31/2023, P2005974 Exp. Date 10/31/2023, P2005814 Exp. Date 10/31/2023, P2005972 Exp. Date 10/31/2023, P2005973 Exp. Date 10/31/2023, P2005998 Exp. Date 10/31/2023, P2005999 Exp. Date 10/31/2023, P2006001 Exp. Date 10/31/2023, P2005997 Exp. Date 10/31/2023, P2006000 Exp. Date 10/31/2023, P2100701 Exp. Date 1/31/2024, P2100702 Exp. Date 1/31/2024, P2100703 Exp. Date 1/31/2024, P2100704 Exp. Date 1/31/2024, P2102512 Exp. Date 3/31/2024, P2101993 Exp. Date 3/31/2024, P2101994 Exp. Date 3/31/2024, P2102951 Exp. Date 4/30/2024, P2102952 Exp. Date 4/30/2024, P2102953 Exp. Date 4/30/2024, P2102954 Exp. Date 4/30/2024, R2100739 Exp. Date 6/30/2024, R2100738 Exp. Date 6/30/2024, R2100740 Exp. Date 6/30/2024, P2104668 Exp. Date 6/30/2024, P2104669 Exp. Date 6/30/2024, P2104670 Exp. Date 6/30/2024, P2105283 Exp. Date 7/31/2024, P2105291 Exp. Date 7/31/2024, P2105282 Exp. Date 7/31/2024, P2105794 Exp. Date 7/31/2024, P2105292 Exp. Date 7/31/2024, P2105297 Exp. Date 7/31/2024, P2105293 Exp. Date 7/31/2024, P2105295 Exp. Date 7/31/2024, P2105294 Exp. Date 7/31/2024, R2101408 Exp. Date 9/30/2024, R2101409 Exp. Date 9/30/2024, R2101410 Exp. Date 9/30/2024, R2101411 Exp. Date 9/30/2024, R2101412 Exp. Date 9/30/2024, R2101413 Exp. Date 9/30/2024, R2200089 Exp. Date 12/31/2024, R2200097 Exp. Date 12/31/2024, R2200100 Exp. Date 12/31/2024, R2200101 Exp. Date 12/31/2024, R2200088 Exp. Date 12/31/2024, P2200775 Exp. Date 1/31/2025, P2200776 Exp. Date 1/31/2025, P2201221 Exp. Date 1/31/2025, P2201347 Exp. Date 2/28/2025, P2201348 Exp. Date 2/28/2025, R2200481 Exp. Date 3/31/2025, R2200576 Exp. Date 4/30/2025, P2203378 Exp. Date 5/31/2025, P2203379 Exp. Date 5/31/2025, P2203377 Exp. Date 5/31/2025, R2200966 Exp. Date 6/30/2025, R2200964 Exp. Date 6/30/2025, R2200973 Exp. Date 6/30/2025, P2204893 Exp. Date 8/31/2025", "more_code_info": ""}, {"country": "United States", "city": "Seminole", "address_1": "6950 Bryan Dairy Rd Ste A", "reason_for_recall": "LABELING: LABEL MIX-UP. Simvastatin tablets, USP 10 mg were found in bottles labeled as Clopidogrel tablets, USP 75 mg.", "address_2": "", "product_quantity": "218772 bottles", "code_info": "Lot #: 117099A, Exp. 08/19", "center_classification_date": "20180220", "distribution_pattern": "Nationwide within the US", "state": "FL", "product_description": "Clopidogrel Tablets, USP 75 mg,  30-count bottles, Rx only,  Packaged for: International Laboratories, LLC St. Petersburg, FL 33710, NDC 54458-888-16", "report_date": "20180207", "classification": "Class I", "openfda": {}, "recalling_firm": "International Laboratories, LLC", "recall_number": "D-0472-2018", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "78913", "termination_date": "20200507", "more_code_info": "", "recall_initiation_date": "20180104", "postal_code": "33777-1606", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Noblesville", "address_1": "14450 Getz Rd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "45", "code_info": "All Sterile Compounded Products within Expiry", "center_classification_date": "20160711", "distribution_pattern": "Nationwide        VA/DOD: CA, KY, MD, NC, OK, TX, VA", "state": "IN", "product_description": "Midazolam HCI1mg/mL in 0.9% Sodium Chloride 100 mL fill in a 150 mL lntravia bag, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0796-48", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Pharmakon Pharmaceuticals, Inc.", "recall_number": "D-1300-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73960", "termination_date": "20180111", "more_code_info": "", "recall_initiation_date": "20160420", "postal_code": "46060-3303", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Completed", "city": "Saint Paul", "state": "MN", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "89805", "recalling_firm": "Fagron, Inc", "address_1": "2400 Pilot Knob Rd", "address_2": "N/A", "postal_code": "55120-1118", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico, Canada, Columbia, France", "recall_number": "D-0856-2022", "product_description": "SyrSpend SF Suspending Base, Cherry Flavored, packaged in a) 500mL bottles (NDC 51552-1123-5) and b) 4L bottles (NDC 51552-1123-9), Rx Only,  Manufactured for Fagron, Inc., St. Paul, MN 55120.", "product_quantity": "a) 559 bottles and b) 243 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Product: Product is contaminated with Burkholderia gladioli.", "recall_initiation_date": "20220304", "center_classification_date": "20220509", "report_date": "20220518", "code_info": "Lot #: a) A67185, Exp. Date 08/31/2024; b) Lot #: A67186, Exp. Date 08/31/2024"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-152-2014", "product_description": "HCG Nasal Spray, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "43 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Port Charlotte", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85404", "recalling_firm": "The Medicine Shoppe Pharmacy", "address_1": "3524b Tamiami Trl", "address_2": "", "postal_code": "33952-8100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Florida", "recall_number": "D-1204-2020", "product_description": "Testosterone in Atrevis 50 mg/mL Gel 30 gm tube, Rx, The Medicine Shoppe Pharmacy, Port Charlotte, FL", "product_quantity": "1 tube", "reason_for_recall": "Lack of Processing Control", "recall_initiation_date": "20200406", "center_classification_date": "20200410", "termination_date": "20221213", "report_date": "20200422", "code_info": "Lot: 44488 Discard by: 8/22/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Moses Lake", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71806", "recalling_firm": "JD & SN Inc., dba Moses Lake Professional Pharmacy", "address_1": "1555 Pilgrim St", "address_2": "N/A", "postal_code": "98837-4623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0148-2016", "product_description": "TRIMIX, injectable Solution, 20MG/1MG/20MCG/ML, 10mL syringe, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA  98837, (509)764-2314", "product_quantity": "155 syringes", "reason_for_recall": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry", "recall_initiation_date": "20150724", "center_classification_date": "20151027", "termination_date": "20160413", "report_date": "20151104", "code_info": "t11242014@14, t10082014@1, t08152014@22, t08042014@31, t07252014@19, t07142015@19, t07102015@24, t07082014@2, t04142015@25, t04062015@16, t02242015@29, 12152014@9, 12032014@4, 11122014@2, 10292014@3, 10012014@15, 09232014@23, 09032014@3, 08132014@1, 06242015@4, 06172015@12, 06102015@5, 05272015@10, 05182015@6, 05132015@9, 05042015@5, 04222015@8, 03112015@4, 02102015@30, 01232015@6, 01072015@5;"}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77770", "recalling_firm": "SCA Pharmaceuticals", "address_1": "8821 Knoedl Ct", "address_2": "N/A", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1016-2017", "product_description": "fentaNYL 3 mcg/mL + BUPIvacaine 0.1% in 0.9% Sodium Chloride 250 mL, Rx only, SCA Pharmaceuticals 8821 Knoedl Ct Little Rock, AR 72205 --- NDC# 70004-0290-40", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; product has the potential to leak.", "recall_initiation_date": "20170714", "center_classification_date": "20170726", "termination_date": "20190501", "report_date": "20170802", "code_info": "Lot: 20170506@27 BUD: 8/4/2017"}, {"status": "Terminated", "city": "Brooklyn", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83136", "recalling_firm": "Infusion Options, Inc.", "address_1": "5924 13th Ave", "address_2": "N/A", "postal_code": "11219-4934", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY only", "recall_number": "D-1796-2019", "product_description": "ORENCIA 750 mg QS 100 ml 0.9% NACL IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190612", "center_classification_date": "20190815", "termination_date": "20250321", "report_date": "20190821", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "North Brunswick", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "71973", "recalling_firm": "Ohm Laboratories, Inc.", "address_1": "1385 Livingston Ave", "address_2": "N/A", "postal_code": "08902-1829", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0020-2016", "product_description": "Rite Aid Pharmacy loratadine orally disintegrating tablets USP, 10 mg, packaged in a) 30-count tablets per box, Item 352712, UPC 0 11822 52712 5; b) 60-count tablets per box, Item 353672, UPC 0 11822 53672 1. Distributed By: Rite Aid, 30 Hunter Lane, Camp Hill, PA 17011.", "product_quantity": "90,410 units", "reason_for_recall": "Superpotent Drug: Out Of Specification (OOS) result for Assay.", "recall_initiation_date": "20150728", "center_classification_date": "20151015", "termination_date": "20161028", "report_date": "20151021", "code_info": "Batch Numbers:    a) 2658137, Exp 11/30/2016; 2644272, Exp 9/30/2016; 2625093, 2625092 Exp 6/30/2016; 2617892, Exp 5/31/2016; 2610783, Exp 4/30/2016;   2600126, 2600128, Exp 2/29/2016  b) 2625093, Exp 6/30/2016; 2617892, Exp 5/31/2016; 2600128, Exp 2/29/2016"}, {"status": "Terminated", "city": "Eatontown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63967", "recalling_firm": "West-ward Pharmaceutical Corp.", "address_1": "465 Industrial Way W", "address_2": "N/A", "postal_code": "07724-2209", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-132-2013", "product_description": "Lisinopril and Hydrochlorothiazide Tablets, 20 mg/25 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1264-01) and b) 1000-count tablets per bottle (NDC 0143-1264-10), Rx only, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ 07724.", "product_quantity": "43,478 bottles", "reason_for_recall": "Presence of Foreign Substance: Reports of gray smudges identified as minute stainless steel particulates were found in the recalled tablets.", "recall_initiation_date": "20121130", "center_classification_date": "20130118", "termination_date": "20140709", "report_date": "20130130", "code_info": "Lot #: 69392A,  69393A, 69394A, 69395A, 69396A, 69397A , Exp 09/15; 69495A, 69496A, 69497A, 69498A, 69524A, 69525A, Exp 10/15"}, {"status": "Terminated", "city": "Aiken", "state": "SC", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "67800", "recalling_firm": "GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline", "address_1": "65 Windham Blvd", "address_2": "N/A", "postal_code": "29805-9384", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-1242-2014", "product_description": "Nicotine polacrilex lozenge, 2 mg, Mint Flavor, 81 count cartons and 189 count cartons. OTC. Labeled Nicorette, Distributed By: GlaxoSmithKline Consumer Healthcare, L.P., Moon Township, PA 15108.  Made in Switzerland. 81 Count NDC: 0135-0510-05, 189 Count NDC: 0135-0510-03.", "product_quantity": "147,684 81 Ct Vials, 130564 189 Ct Vials", "reason_for_recall": "Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.", "recall_initiation_date": "20140220", "center_classification_date": "20140418", "termination_date": "20170120", "report_date": "20140430", "code_info": "81 Ct Vial, Lot # 13727 (exp 8/14), 13816 (exp 10/14), & 13965 (exp 12/14); 189 Ct Vial, Lot # 12H17N (exp 4/14), 12H20N (exp 6/14), 12J16N (exp 6/14), 12K03N (exp 9/14), 12L05N (exp 10/14), 12L07N (exp 9/14), 12L17N (exp 10/14), 13A04N (exp 11/14), 13A23N (exp 11/14), 13C04N (exp 1/15), 13C08N (exp 1/15), 13D17N (exp 11/14), 13D18N (exp 1/15), 13D18N1 (exp 3/15), 13E24N (exp 4/15), 13E28N (exp 4/15), 13G16N (exp 4/15), 13G17N (exp 5/14), 13H02N (exp 5/15), 13H22N (exp 5/15), 13I18N (exp 8/15), 13I20N (exp 5/15), 13J24N (exp 8/15), 13J24N1 (exp 9/15), 13K08N (exp 8/15), 13K11N (exp 9/15), 13L11N (exp 10/15) & 13L11N1 (exp 10/15).", "more_code_info": ""}, {"status": "Ongoing", "city": "Minneapolis", "state": "MN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93829", "recalling_firm": "IntegraDose Compounding Services LLC", "address_1": "719 Kasota Ave Se", "address_2": "N/A", "postal_code": "55414-2842", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MN only", "recall_number": "D-0258-2024", "product_description": "Vasopressin 2 Unit/2 mL in 0.9% Sodium Chloride, 2 mL per syringe, Rx Only, 719 Kasota Ave SE, Minneapolis, MN. NDC 71139-0190-1", "product_quantity": "281 syringes", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20240112", "center_classification_date": "20240122", "report_date": "20240131", "code_info": "Lot #: 20230921VAS-2, Exp. Date 03/19/2024"}, {"status": "Terminated", "city": "Boothwyn", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65180", "recalling_firm": "Pentec Health", "address_1": "4 Creek Pkwy Ste A", "address_2": "N/A", "postal_code": "19061-3132", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dialysis Centers  Direct to patient", "recall_number": "D-588-2013", "product_description": "Proplete 60 - 69 KG (Intradialytic Parenteral Nutrition - dialysate solution with added amino acids), in 555mL bag, Pentec Health Inc, 4 Creek Parkway Suite A  Boothwyn, PA  19061-3132", "product_quantity": "59 Bags", "reason_for_recall": "Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions.", "recall_initiation_date": "20130515", "center_classification_date": "20130606", "termination_date": "20141216", "report_date": "20130612", "code_info": "Compounding Date: 04/23/13, 04/24/13, 04/29/13, 05/01/13    Discard after: 05/20/13, 05/22/13"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78828", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0438-2018", "product_description": "Lidocaine HCl in all strengths, all doses, and all packaging.", "product_quantity": "Unknown", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20171227", "center_classification_date": "20180220", "termination_date": "20200507", "report_date": "20180228", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Dayton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83581", "recalling_firm": "Aurolife Pharma, LLC", "address_1": "2400 US Highway 130", "address_2": "N/A", "postal_code": "08810-1519", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1869-2019", "product_description": "Allergy Relief (Fexofenadine HCl) tablets USP, 180 mg, 15-count cartons, equate, Distributed by: Wal-Mart Stores, Inc., Bentonville, AR  72716, NDC 49035-995-62.", "product_quantity": "129,600 cartons", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20190823", "center_classification_date": "20190917", "termination_date": "20220816", "report_date": "20190925", "code_info": "Lot #s: 067180010A, Exp 03/21; 067180023C1, 067180024D1, Exp 07/21"}, {"status": "Completed", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90204", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands", "recall_number": "D-0927-2022", "product_description": "Formula F1 Papaverine 1.8 mg/mL Phentolamine 0.2 mg/mL Alprostadil 18 mcg/mL Atropine 0.02 mg/mL, Packaged as a)2.5 mL Multi-Dose vial, NDC 73198-0001-03; b) 10 mL Multi-Dose vial, NDC 73198-0001-10; Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835", "product_quantity": "1703 vials", "reason_for_recall": "Lack of assurance of sterility.", "recall_initiation_date": "20220509", "center_classification_date": "20220525", "report_date": "20220601", "code_info": "Lots: K41C09, K41B09 BUD: 11/9/2022, and A24C19-22 BUD: 1/19/2023", "more_code_info": ""}, {"country": "United States", "city": "Berkeley", "address_1": "2320 Woolsey St", "reason_for_recall": "Lack of Assurance of Sterility: Firm is recalling all unexpired lots of sterile compounded products after FDA inspection found concerns of lack of sterility assurance.", "address_2": "", "product_quantity": "5 ml", "code_info": "All lots", "center_classification_date": "20160217", "distribution_pattern": "CA", "state": "CA", "product_description": "papaverine prostaglandin 30 mg/30 mcg/mL, 5 mL unit size, refrigerate, This Rx is Compounded, Abbott's Compounding Pharmacy, Berkeley, CA 94705", "report_date": "20160224", "classification": "Class II", "openfda": {}, "recalling_firm": "Abbott's Compounding Pharmacy, Inc.", "recall_number": "D-0688-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73090", "termination_date": "20170406", "more_code_info": "", "recall_initiation_date": "20160115", "postal_code": "94705-1973", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Maple Grove", "address_1": "6701 Evenstad Drive", "reason_for_recall": "Failed Dissolution Test Requirements", "address_2": "", "product_quantity": "60 bottles", "code_info": "Lot #308198, Expiration Date is 03/2014", "center_classification_date": "20130208", "distribution_pattern": "FL, NJ.", "state": "MN", "product_description": "Propranolol Hydrochloride Extended-release Capsules, USP, 80 mg, 100 Capsules, Rx only, Manufactured for Upsher Smith Laboratories, Inc Minneapolis MN 55447  ---  NDC 0245-0085-11, UPC 3 0245-0085-11 9", "report_date": "20130220", "classification": "Class II", "openfda": {}, "recalling_firm": "Upsher Smith Laboratories, Inc.", "recall_number": "D-160-2013", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "63908", "termination_date": "20130712", "more_code_info": "", "recall_initiation_date": "20121120", "postal_code": "55369", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Schaumburg", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA204216"], "brand_name": ["KETOROLAC TROMETHAMINE"], "generic_name": ["KETOROLAC TROMETHAMINE"], "manufacturer_name": ["Sagent Pharmaceuticals"], "product_ndc": ["25021-700", "25021-701"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["KETOROLAC TROMETHAMINE"], "rxcui": ["860092", "1665459", "1665461"], "spl_id": ["ff55e1ab-2a8d-4a56-8b72-5e0a8e00d866"], "spl_set_id": ["62591551-a644-4b2c-a0de-982e906fabc3"], "package_ndc": ["25021-700-01", "25021-701-01", "25021-701-02"], "is_original_packager": [true], "unii": ["4EVE5946BQ"]}, "product_type": "Drugs", "event_id": "69485", "recalling_firm": "Sagent Pharmaceuticals Inc", "address_1": "1901 N Roselle Rd Ste 700", "address_2": "N/A", "postal_code": "60195-3194", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-0027-2015", "product_description": "Ketorolac Tromethamine INJECTION, USP, 30 mg per mL, a) 1 mL vial (NDC 25021-701-01) b) 2 mL vial (NDC 25021-701-02), Rx only, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195", "product_quantity": "69,050 vials", "reason_for_recall": "Incorrect or Missing Lot and/or Exp Date:  Ketorolac Tromethamine Injection, is being recalled as a result of labeling the product with the incorrect expiration date.", "recall_initiation_date": "20141003", "center_classification_date": "20141016", "termination_date": "20160223", "report_date": "20141022", "code_info": "Lot MP5021, Exp. 04/16; Lots MP5024, MP5025, Exp. 05/16"}, {"status": "Ongoing", "city": "Denver", "state": "CO", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "97779", "recalling_firm": "STAQ Pharma, Inc.", "address_1": "14135 E 42nd Ave Ste 50", "address_2": "", "postal_code": "80239-5214", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0023-2026", "product_description": "Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use, 50 mL Syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0104-05.", "product_quantity": "", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date", "recall_initiation_date": "20251009", "center_classification_date": "20251015", "report_date": "20251022", "code_info": "Lot #: 25104595A, Expiry: 27DEC2025.", "more_code_info": ""}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "16 units", "code_info": "Rx #'s:   0392878,  0398614,  0394932,  0394932,  0387461,  0352013,  0391247,  0391792,  0399973,  0401614,  0402893,  0392721,  0392721,  0382234", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "ALTEPLASE, SDPF - (0.05ML SYRINGE, 30G, 1/2\") 1000MCG/ML INJECTABLE 0.05 ML; ALTEPLASE, SDPF - (0.15ML LL SYRINGE, NO NEEDLE) 100MCG/ML (10MCG/0.1ML) INJECTA 0.15 ML, 0.3 ML; ALTEPLASE, SDPF - (0.1ML SYRINGE, 30G, 1/2\") 1000MCG/ML INJECTABLE 0.1 ML, 0.2 ML, 0.3 ML;  ALTEPLASE, SDPF - (0.1ML SYRINGE, 30G, 1/2\") 100MCG/ML (10MCG/0.1ML) INJECTABLE 0.1 ML, 0.3 ML; ALTEPLASE, SDPF - (0.1ML SYRINGE, 30G, 1/2\") 250MCG/ML (25MCG/0.1ML) INJECTABLE 0.1 ML (9 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1453-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Hoover", "state": "AL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72101", "recalling_firm": "Eagle Pharmacy, Inc.", "address_1": "2200 Riverchase Ctr Ste 675", "address_2": "N/A", "postal_code": "35244-2918", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "TN, AL", "recall_number": "D-1832-2015", "product_description": "LIPO B STERILE INJECTION 10 mL ( Methionine 25 mg, Inositol 50 mg, Choline Chloride 50 mg, Pyridoxine Hydrochloride 5 mg, Methylcobalamin 0.1mg, Benzyl Alcohol, Sterile Water, Sodium Hydroxide, Hydrochloric Acid), Multidose vial,  Rx Only,  Compounded by Eagle Pharmacy, Birmingham, AL 35244", "product_quantity": "104 vials", "reason_for_recall": "Subpotent Drug: trace amounts of methylcobalamin in compounded drug.", "recall_initiation_date": "20150828", "center_classification_date": "20150929", "termination_date": "20151130", "report_date": "20151007", "code_info": "Lot # 07072015LIPO; Exp. 12/15"}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021301"], "brand_name": ["LEVOXYL"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "product_ndc": ["60793-850", "60793-851", "60793-852", "60793-853", "60793-854", "60793-855", "60793-856", "60793-857", "60793-858", "60793-859", "60793-860"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "966157", "966164", "966170", "966175", "966184", "966190", "966194", "966200", "966204", "966211", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270", "966283"], "spl_id": ["e230c170-2a16-47d0-bce7-ac0414c192f7"], "spl_set_id": ["758588c3-c63e-491b-0aa2-4f50d80cb174"], "package_ndc": ["60793-850-10", "60793-850-01", "60793-851-10", "60793-851-01", "60793-852-10", "60793-852-01", "60793-853-10", "60793-853-01", "60793-854-10", "60793-854-01", "60793-855-10", "60793-855-01", "60793-856-10", "60793-856-01", "60793-857-10", "60793-857-01", "60793-858-10", "60793-858-01", "60793-859-10", "60793-859-01", "60793-860-10", "60793-860-01"], "is_original_packager": [true], "upc": ["0360793856018", "0360793850016", "0360793852010", "0360793851013", "0360793857015", "0360793853017", "0360793854014", "0360793858012", "0360793855011", "0360793859019", "0360793860015"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "75691", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0150-2017", "product_description": "LEVOXYL(R) (levothyroxine sodium tablets, USP), 200 mcg, 100 count bottles, Rx only, Manufactured and Distributed by:  King Pharmaceuticals, Inc., Bristol, TN 37620, NDC 60793-860-01", "product_quantity": "2,666 bottles", "reason_for_recall": "Superpotent", "recall_initiation_date": "20161107", "center_classification_date": "20161123", "termination_date": "20200501", "report_date": "20161130", "code_info": "16H21, Exp. 08/2017"}, {"status": "Terminated", "city": "Belleville", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M017"], "brand_name": ["MAXIMUM STRENGTH HYDROCORTISONE CREAM"], "generic_name": ["HYDROCORTISONE CREAM"], "manufacturer_name": ["Walgreens"], "product_ndc": ["0363-0638"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["HYDROCORTISONE"], "rxcui": ["106258"], "spl_id": ["39dbd2fe-dc98-75c7-e063-6294a90a653c"], "spl_set_id": ["a7db0a6f-ceca-4e77-bad7-55c3c74413a7"], "package_ndc": ["0363-0638-02", "0363-0638-04"], "is_original_packager": [true], "upc": ["0311917182476", "311917182476"], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["WI4X0X7BPJ"]}, "product_type": "Drugs", "event_id": "83316", "recalling_firm": "US Pharmaceuticals Inc.", "address_1": "681 Main St Ste 27", "address_2": "N/A", "postal_code": "07109-3471", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-1734-2019", "product_description": "Hydrocortisone Cream, Hydrocortisone 1% / Anti-Itch Cream, 2 OZ (56 g) tube. Distributed By: Walgreen Co. 200 Wilmot Rd., Deerfield, IL 60015. NDC #0363-0638-04, UPC 3 11917 18247 6", "product_quantity": "651 cases", "reason_for_recall": "CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.", "recall_initiation_date": "20190711", "center_classification_date": "20190813", "termination_date": "20200625", "report_date": "20190821", "code_info": "Lot #56J17 EXP 07/2019"}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0457-2020", "product_description": "Accutome Rx Accu-WASH, 4 FL OZ (118 mL), Manufactured for: Accutome Inc 3222 Phoenixville Pike Malvern, PA 19355 USA, Mfd. By: Altaire Pharmaceuticals, Inc. Aquebogue, NY 11931, NDC 63448-411-04", "product_quantity": "90,072 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "16250 09/19 17088 03/20 17307 10/20 17323 10/20 18014 1/21 18228 9/21 18261 10/21 19119 4/22"}, {"status": "Terminated", "city": "Augusta", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64661", "recalling_firm": "Clinical Specialties Compounding Pharmacy", "address_1": "318 Baston Rd", "address_2": "N/A", "postal_code": "30907", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "FL, GA and SC.", "recall_number": "D-643-2013", "product_description": "HCG 1000 units/ml, 30 mL syringe, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "recall_initiation_date": "20130320", "center_classification_date": "20130703", "termination_date": "20170222", "report_date": "20130710", "code_info": "Lot number CABDAHAD:04 Exp date: 5/6/2013."}, {"status": "Completed", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021301"], "brand_name": ["LEVOXYL"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "product_ndc": ["60793-850", "60793-851", "60793-852", "60793-853", "60793-854", "60793-855", "60793-856", "60793-857", "60793-858", "60793-859", "60793-860"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "966157", "966164", "966170", "966175", "966184", "966190", "966194", "966200", "966204", "966211", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270", "966283"], "spl_id": ["e230c170-2a16-47d0-bce7-ac0414c192f7"], "spl_set_id": ["758588c3-c63e-491b-0aa2-4f50d80cb174"], "package_ndc": ["60793-850-10", "60793-850-01", "60793-851-10", "60793-851-01", "60793-852-10", "60793-852-01", "60793-853-10", "60793-853-01", "60793-854-10", "60793-854-01", "60793-855-10", "60793-855-01", "60793-856-10", "60793-856-01", "60793-857-10", "60793-857-01", "60793-858-10", "60793-858-01", "60793-859-10", "60793-859-01", "60793-860-10", "60793-860-01"], "is_original_packager": [true], "upc": ["0360793856018", "0360793850016", "0360793852010", "0360793851013", "0360793857015", "0360793853017", "0360793854014", "0360793858012", "0360793855011", "0360793859019", "0360793860015"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "64835", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and PR", "recall_number": "D-260-2013", "product_description": "Levoxyl (levothyroxine sodium) tablets, USP 175 mcg, packaged in a) 100-count bottles (NDC 60793-859-01) and b) 1000-count bottles ( NDC 60793-859-10 ) Rx only, Manufactured and Distributed by:  King Pharmaceuticals, Inc., Bristol, TN  37620.", "product_quantity": "10121 bottles", "reason_for_recall": "Chemical contamination: emission of strong odor after package was opened.", "recall_initiation_date": "20130328", "center_classification_date": "20130418", "report_date": "20130424", "code_info": "Lot # a) 67507B, Exp. 02/14; b) 67508B, Exp. 02/14"}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63384", "recalling_firm": "Raritan Pharmaceuticals, Inc.", "address_1": "8 Joanna Ct", "address_2": "N/A", "postal_code": "08816-2108", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-029-2013", "product_description": "Simply Right Healthcare Fiber Capsules, 100% Natural Psyllium Fiber, Fiber Supplement, Fiber Laxative for Regularity, 400 capsules per bottle,  Distributed by: SAM'S West, Inc., Bentonville, AR 72716, UPC 0-78742-00524-9.", "product_quantity": "46,104 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Product is being recalled due to possible microbial contamination by C. difficile discovered in the raw material.", "recall_initiation_date": "20120904", "center_classification_date": "20121025", "termination_date": "20141007", "report_date": "20121031", "code_info": "Lots 16273, Exp 06/15; 16460,  16464, 16466, 16468, 16469, Exp 07/15"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1026-2023", "product_description": "TRANSPLANT SOLUTION, Plasma-Lyte A - 75 ml, MSA/MSG 0.92 Molar -60 ml, dextrose 70% 21.3 ml; IV Bag, Total Volume = 165 mL, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0014-2", "product_quantity": "12 IV bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot:36-252141, Exp. 7/16/2023."}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090161"], "brand_name": ["DIVALPROEX SODIUM"], "generic_name": ["DIVALPROEX SODIUM"], "manufacturer_name": ["Dr. Reddy's Laboratories Ltd"], "product_ndc": ["55111-533"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DIVALPROEX SODIUM"], "rxcui": ["1099563"], "spl_id": ["bbff7587-1b4e-6616-e6f5-689bc89e1aea"], "spl_set_id": ["2e35f833-1cf7-12eb-9567-7a191e32e138"], "package_ndc": ["55111-533-30", "55111-533-60", "55111-533-01", "55111-533-05", "55111-533-79", "55111-533-78"], "is_original_packager": [true], "unii": ["644VL95AO6"]}, "product_type": "Drugs", "event_id": "71374", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1135-2015", "product_description": "Divalproex Sodium Extended-Release Tablets, USP, (valproic acid activity), 250 mg, 100 count (NDC 55111-533-01) and 500 count (NDC 55111-533-05) bottles, Rx Only, Mfd. By. Dr. Reddy's Laboratories Limited, Bachupally 500 090 India", "product_quantity": "100 count 7479; 500 count - 2544", "reason_for_recall": "Failed Dissolution Specifications; exceeded specification at the 9 hour time point", "recall_initiation_date": "20150522", "center_classification_date": "20150612", "termination_date": "20170424", "report_date": "20150624", "code_info": "100 count bottle - Lot #C307859, exp 09/2015;     500 count bottle - Lot #C307859 and Lot# C307812, exp 09/2015", "more_code_info": ""}, {"status": "Terminated", "city": "Burbank", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "90481", "recalling_firm": "Bryant Ranch Prepack, Inc.", "address_1": "1919 N Victory Pl", "address_2": "", "postal_code": "91504-3425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed to one wholesaler in AL for further distribution in the US.", "recall_number": "D-1187-2022", "product_description": "Morphine Sulfate extended-Release Tablets, USP; 30 mg, 100-count bottles, Rx only, manufactured by: Ohm Laboratories Inc., New Brunswick NJ 08901 USA; Relabeled by: Bryant Ranch Prepack, Inc., Burbank, CA, 91504 USA, NDC: 63629-1088-01.", "product_quantity": "", "reason_for_recall": "Labeling: Label Mix-up:  bottles labeled as Morphine Sulfate 60 mg Extended-Release tablets contain Morphine Sulfate 30 mg Extended-Release tablets and bottles labeled as Morphine Sulfate 30 mg Extended-Release tablets may contain Morphine Sulfate 60 mg Extended-Release tablets.", "recall_initiation_date": "20220617", "center_classification_date": "20220708", "termination_date": "20240402", "report_date": "20220720", "code_info": "Lot #: 179642, Exp. Date 11/30/2023.", "more_code_info": ""}, {"status": "Terminated", "city": "Charlotte", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["505G(a)(3)"], "brand_name": ["REFRESH ANTIBAC FOAM"], "generic_name": ["BENZALKONIUM CHLORIDE"], "manufacturer_name": ["SC Johnson Professional USA, Inc."], "product_ndc": ["11084-010"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["BENZALKONIUM CHLORIDE"], "rxcui": ["1046593"], "spl_id": ["ebf3eb0f-7d6a-42c0-9a1c-3eee60202dad"], "spl_set_id": ["884d1c8c-5643-423e-8ed4-d2ef38f8af73"], "package_ndc": ["11084-010-40", "11084-010-27", "11084-010-12", "11084-010-20", "11084-010-05", "11084-010-01", "11084-010-55", "11084-010-96", "11084-010-66"], "is_original_packager": [true], "upc": ["0069124050070"], "unii": ["F5UM2KM3W7"]}, "product_type": "Drugs", "event_id": "81453", "recalling_firm": "S.C. Johnson Professional", "address_1": "2815 Coliseum Centre Dr Ste 600", "address_2": "", "postal_code": "28217-0144", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "NC", "recall_number": "D-0220-2019", "product_description": "deb stoko, Refresh AntiBac FOAM (benzalkonium chloride), 0.13%, 1 L (33.8 fl. oz.) cartridge packaged in 8 cartridges per case, Made in the USA, Deb USA, Inc., Charlotte, NC  28217, NDC 11084-010-27.", "product_quantity": "869 cases", "reason_for_recall": "CGMP Deviations: Product was released to market prior to microbiological testing.", "recall_initiation_date": "20181026", "center_classification_date": "20181106", "termination_date": "20200908", "report_date": "20181114", "code_info": "Lot 9131", "more_code_info": ""}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "10 units", "code_info": "Rx #'s:N0406290, N0387600, N0390988, N0393344, N0396645, N0400013, N0403729, N0406665, N0410203, N0393490", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "BACLOFEN/BUPIVACAINE/CLONIDINE/MORPHINE, P.F. 1000MCG/7.5MG/1000MCG/50MG/ML INTR 40 ML; BACLOFEN/BUPIVACAINE/CLONIDINE/MORPHINE, P.F. 50MCG/2MG/200MCG/50MG/ML INTRATHEC 18 ML; BACLOFEN/CLONIDINE/BUPIVACAINE/MORPHINE, P.F. 500MCG/1/7.5/50MG/ML INTRATHECAL 40 ML (3 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1460-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Plattsburgh", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89059", "recalling_firm": "SterRx, LLC", "address_1": "141 Idaho Ave", "address_2": "", "postal_code": "12903-3987", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0308-2022", "product_description": "EPINEPHIrine in 0.9% Sodium Chloride Injection, 4 mg per 250 mL (16 mcg per mL), Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-227-01.", "product_quantity": "26,928 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20211112", "center_classification_date": "20211229", "termination_date": "20231206", "report_date": "20220105", "code_info": "S21254/BWZ 22-Nov-21  S21263/BXG 30-Nov-21  S21333/BZT 11-Jan-22  S21398/CCG 19-Feb-22", "more_code_info": ""}, {"status": "Terminated", "city": "Largo", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65756", "recalling_firm": "VistaPharm, Inc.", "address_1": "7265 Ulmerton Rd", "address_2": "N/A", "postal_code": "33771-4809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide.", "recall_number": "D-913-2013", "product_description": "Nystatin Oral Suspension, USP 500,000 units/ 5 mL  (NDC 66689-037-01 ) Rx Only,  Manufactured by VistaPharm, Inc. Largo, FL 33771", "product_quantity": "1,707,050 cups / 5ml ea.", "reason_for_recall": "Failed Impurites/Degradation Specifications: Test failure of single largest peak at 18 months.", "recall_initiation_date": "20130704", "center_classification_date": "20130821", "termination_date": "20140804", "report_date": "20130828", "code_info": "Lot # 240200, 243000, 244800, 245600, 250800 and 253600. Exp 06/13."}, {"status": "Terminated", "city": "Port Charlotte", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85404", "recalling_firm": "The Medicine Shoppe Pharmacy", "address_1": "3524b Tamiami Trl", "address_2": "", "postal_code": "33952-8100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Florida", "recall_number": "D-1175-2020", "product_description": "Estriol Vaginal Cream (0.1%) 1 mg Cream 30 GM tubes, Rx, The Medicine Shoppe Pharmacy, Port Charlotte, FL", "product_quantity": "8 tubes", "reason_for_recall": "Lack of Processing Control", "recall_initiation_date": "20200406", "center_classification_date": "20200410", "termination_date": "20221213", "report_date": "20200422", "code_info": "Lot: 45036 Discard by: 7/31/2020; 45075 Discard by:8/7/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72455", "recalling_firm": "Downing Labs, LLC", "address_1": "4001 McEwen Rd Suite 110", "address_2": "N/A", "postal_code": "75244-5020", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the US; Australia, Brazil, Bahamas, Switzerland, France, Colombia, Hong Kong, Indonesia, India, Japan, Malaysia, New Zealand, Phillippines, Singapore, Thailand, Trinidad and Tobago, Taiwan", "recall_number": "D-0363-2016", "product_description": "Calcium Gluconate (680mOsm/L) Injection 10%, 50mL vial, Rx only, Downing Labs, LLC 4001 McEwen Rd, Suite 110, Dallas TX, 754244, 1-800-914-7435", "product_quantity": "286 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20151016", "center_classification_date": "20151118", "termination_date": "20160922", "report_date": "20151125", "code_info": "All lots"}, {"status": "Terminated", "city": "Foshan", "state": "N/A", "country": "China", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80614", "recalling_firm": "Longbow First Aid Products Manufactory", "address_1": "Building F/2", "address_2": "A3 Guiping Road; Hantian Industrial Park", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY and CA.", "recall_number": "D-1048-2018", "product_description": "Emergency First Aid Eyewash (Purified Water 98.3%), packaged in a)  4fl oz. (118 ml) NDC 7110500002, and b) 0.67 fl (20 ml) NDC 71150000) bottles, Manufactured for: Redicare LLC, Congers, NY", "product_quantity": "30,000 bottles", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20180717", "center_classification_date": "20180808", "termination_date": "20190911", "report_date": "20180815", "code_info": "Lot #: a) 20171210, Exp. 12/2022; b) 20171210, Exp. 12/2022"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0201-2019", "product_description": "Trimix Papaverine/Phentolamine/Alprostadil 30 mg/1 mg/60 mcg Powder Pharm D Solutions, Houston, Texas --- NDC 69699-1367-02", "product_quantity": "430 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 06132018:87 Discard by: 12/10/2018; 05302018:66 Discard by: 11/25/2018; 06122018:54 Discard by: 11/17/2018; 07252018:88 Discard by: 1/21/2019"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "48 ml total volume", "code_info": "All lots distributed between November 2014 and May 2015;  03312015@25, 5/30/2015; 03312015@45, 5/30/2015; 03312015@50, 5/30/2015; 04292015@58, 6/28/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "HCG 1,000 IU/ml + Methylcobalamin 1 mg/ml Injection, Multi-Dose Vial, Sterile, Refrigerate, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1507-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Suffern", "address_1": "25 Old Mill Rd", "reason_for_recall": "Failed Stability Specification: out of specification result obtained for the Particle Size Distribution test during stability testing.", "address_2": "", "product_quantity": "19,658 packs", "code_info": "Lot #: F8011, Exp May 2015", "center_classification_date": "20150615", "distribution_pattern": "NJ via 1 distributor", "state": "NY", "product_description": "Foradil Aerolizer (formoterol fumarate inhalation powder) 12 mcg per capsule,  12 Capsules (Blister strips of 6) per pack. For inhalation use only, Rx only, Manufactured for: Merck Sharp & Dohme Corp., a subsidiary of MERCK & CO., INC. Whitehouse Station, NJ 08889.  Manufactured by: Novartis Pharma AG Basle,Via Serafino Balestra 31 Locarno, Switzerland.", "report_date": "20150624", "classification": "Class III", "openfda": {}, "recalling_firm": "Novartis Pharmaceuticals Corp.", "recall_number": "D-1137-2015", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "71310", "termination_date": "20160518", "more_code_info": "", "recall_initiation_date": "20150522", "postal_code": "10901-4106", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Coventry", "state": "RI", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA205831"], "brand_name": ["APTENSIO XR"], "generic_name": ["METHYLPHENIDATE HYDROCHLORIDE"], "manufacturer_name": ["Rhodes Pharmaceuticals L.P."], "product_ndc": ["42858-401", "42858-402", "42858-403", "42858-404", "42858-405", "42858-406", "42858-407"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METHYLPHENIDATE HYDROCHLORIDE"], "spl_id": ["0a491e4a-bf25-46f7-abce-58c2dfa8f30c"], "spl_set_id": ["5adedc01-ebf0-11e3-ac10-0800200c9a66"], "package_ndc": ["42858-401-45", "42858-402-45", "42858-403-45", "42858-404-45", "42858-405-45", "42858-406-45", "42858-407-45"], "is_original_packager": [true], "upc": ["0342858404457", "0342858403450", "0342858402453", "0342858401456"], "unii": ["4B3SC438HI"]}, "product_type": "Drugs", "event_id": "79820", "recalling_firm": "Rhodes Pharmaceuticals, L.P.", "address_1": "498 Washington St", "address_2": "N/A", "postal_code": "02816-5467", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the USA", "recall_number": "D-0710-2018", "product_description": "Aptensio XR (methylphenidate HCl extended-release) capsules 15 mg Rx Only 90-count bottle. Marketed by: Rhodes Pharmaceuticals L.P., Coventry, RI 02816. Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834. NDC 42858-402-45", "product_quantity": "2454 bottles", "reason_for_recall": "Failed Dissolution Specification: Low dissolution outside of specifications", "recall_initiation_date": "20180417", "center_classification_date": "20180503", "termination_date": "20200519", "report_date": "20180509", "code_info": "Lot# AG8679B Exp. 01/2020"}, {"status": "Ongoing", "city": "Dania Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94788", "recalling_firm": "Little Moon Essentials LLC", "address_1": "501 Old Griffin Rd", "address_2": "N/A", "postal_code": "33004-2774", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Ontario, Canada (2 retailers)", "recall_number": "D-0573-2024", "product_description": "Little Moon Essentials, Aching Head Rub (Camphor 3.09%, Menthol 2.55%) , a) 0.5OZ (14G), metal tin, UPC Code 67367388226 8, NDC 70722-203-05; b)1OZ (28G) glass jar, UPC Code 6 73673 88203 9, NDC 70722-203-01; Little Moon Essentials LLC Dania Beach, Fl 33004", "product_quantity": "6,312 tin and glass jars", "reason_for_recall": "CGMP deviations", "recall_initiation_date": "20240620", "center_classification_date": "20240702", "report_date": "20240710", "code_info": "lot code No expiration date on product: a) 326070, 420140,  b) 322030, 321230, 329230, 321240, 329170, 328280, 326090, 322290, 327021, 323121, 327221, 429210, 424130, 427050"}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0044-2019", "product_description": "Premier Value Nasal Decongestant Extra Moisturizing Nasal Spray (Oxymetazoline HCl 0.05%), 1 FL OZ (30 mL) bottle, Distributed By Chain Drug Consortium, 3301 NW Boca Raton Blvd, Suite 101, Boca Raton, FL 33431, NDC 68016-304-03, UPC 8 40986 01518 2.", "product_quantity": "8592 bottles", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; sulfaSALAzine Tablet, 500 mg may be potentially mislabeled as    HYOSCYAMINE SULFATE SL, Tablet, 0.125 mg, NDC 00574025001, Pedigree: AD46265_7, EXP: 5/15/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "sulfaSALAzine, Tablet, 500 mg has the following code    Pedigree: AD46265_13, EXP: 5/15/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "sulfaSALAzine, Tablet, 500 mg, Rx only, Distributed by: AidaPak Service, LLC,  NDC 59762500001", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-648-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Brookhaven", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078476"], "brand_name": ["FOSPHENYTOIN SODIUM"], "generic_name": ["FOSPHENYTOIN"], "manufacturer_name": ["Amneal Pharmaceuticals LLC"], "product_ndc": ["70121-1381", "70121-1390"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["FOSPHENYTOIN SODIUM"], "rxcui": ["1670195", "1670200"], "spl_id": ["bd30ea3a-8a0f-407a-8664-d61fd4711ed0"], "spl_set_id": ["39b58213-b9e2-4847-9010-99e187c1b778"], "package_ndc": ["70121-1390-1", "70121-1390-7", "70121-1381-1", "70121-1381-5"], "is_original_packager": [true], "upc": ["0370121139072", "0370121138150"], "unii": ["7VLR55452Z"]}, "product_type": "Drugs", "event_id": "79610", "recalling_firm": "Amneal Pharmaceuticals", "address_1": "50 Horseblock Rd", "address_2": "", "postal_code": "11719-9509", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A Nationwide", "recall_number": "D-0610-2018", "product_description": "Fosphenytoin Sodium Injection, USP 500 mg PE*/10 mL, Made in India. Distributed by: Amneal Biosciences, Bridgewater, NJ 08807, NDC 70121-1390-1", "product_quantity": "12,584 vials", "reason_for_recall": "Presence of particulate matter", "recall_initiation_date": "20171215", "center_classification_date": "20180329", "termination_date": "20200803", "report_date": "20180404", "code_info": "Lot #: AP160022, AP160023, Exp. 05/2018; AP16038, AP160039, AP160040, Exp. 06/2018; AP160076, AP160077, AP160078, Exp. 12/2018", "more_code_info": ""}, {"status": "Terminated", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72746", "recalling_firm": "Sentara Enterprises", "address_1": "535 Independence Pkwy Ste 300", "address_2": "N/A", "postal_code": "23320-5176", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "U.S. Including: VA, NC", "recall_number": "D-0614-2016", "product_description": "Parenteral Amino Acid Infusion 10%, Packaged in a) 780ML Homepumps, b) 1000ML Homepumps, c) 1140ML Homepumps, d) 1152ML Homepumps, e) 1400ML Homepumps, f) 1440ML Homepumps, g) 1500ML Homepumps, h) 1700ML Homepumps, i) 1900ML Homepumps, j) 2130ML Homepumps, k) 2250ML Homepumps, l) 2400ML Homepumps, m) 2650ML Homepumps, n) 2700ML Homepumps, o) 3250ML Homepumps, p) 3390ML Homepumps, and q) 3500ML Homepumps, Rx Only. SENTARA HOME HEALTH SENTARA RX, 535 Independence Pkwy ste.300, Chesapeake, VA 23320-5176.", "product_quantity": "a) 7, b) 7, c) 6, d) 7, e) 4,  f) 13, g) 2,  h) 4,  i) 7,  j) 5,  k) 10,  l) 11, m) 11, n) 11, o) 7, p) 7, q) 7 Bags", "reason_for_recall": "Lack of Assurance of Sterility: Product sterility cannot be guaranteed.", "recall_initiation_date": "20150918", "center_classification_date": "20160128", "termination_date": "20160629", "report_date": "20160203", "code_info": "All Lots compounded between 11-Sep-15 and 17-Sep-15. Expiries: a) 26-Sep-15, b) 16-Sep-15 c) 25-Sep-15, d) 25-Sep-15 e) 20-Sep-15, 26-Sep-15, f) 20-Sep-15, 24-Sep-15, g) 20-Sep-15, 26-Sep-15, h) 20-Sep-15, i) 15-Sep-15, j) 26-Sep-15, k) 25-Sep-15, 26-Sep-15, l) 20-Sep-15, 23-Sep-15, m) 20-Sept-15, 24-Sep-15, 26-Sep-15, n) 23-Sep-15, o) 20-Sep-15, p) 26-Sep-15, q) 20-Sep-15"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: MIDODRINE HCL, Tablet, 2.5 mg may have potentially been mislabeled as the following drug:  PIOGLITAZONE HCL, Tablet, 15 mg, NDC 00093204856, Pedigree: W003264, EXP: 6/17/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "MIDODRINE HCL, Tablet, 2.5 mg has the following codes:   Pedigree: W003265, EXP: 6/17/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "MIDODRINE HCL, Tablet, 2.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00185004001.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-877-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Baltimore", "address_1": "Harborplace Tower", "reason_for_recall": "Failed Tablet/Capsule Specifications: Complaints related to crumbling of tablets when popped out of the blister pack.", "address_2": "111 S Calvert St Fl 21st", "product_quantity": "41,863 cartons/3 wallets per carton", "code_info": "Lot: H801227, Exp. Date January 2020", "center_classification_date": "20200103", "distribution_pattern": "Nationwide within the United States", "state": "MD", "product_description": "Blisovi Fe  1.5/30 (norethindrone acetate and ethinyl estradiol tablets USP and ferrous fumarate tablets 75mg), Rx Only, Distributed by: Lupin Pharmaceuticals Inc Baltimore, MD 21202, Manufactured for: Lupin Limited Pithampur 454775 INDIA 240875, NDC 68180-866-11", "report_date": "20200115", "classification": "Class II", "openfda": {}, "recalling_firm": "Lupin Pharmaceuticals Inc.", "recall_number": "D-0638-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "84571", "termination_date": "20201022", "recall_initiation_date": "20191226", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Henderson", "state": "NV", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80343", "recalling_firm": "Gaia Ethnobotanical LLC", "address_1": "2752 Botticelli Dr", "address_2": "", "postal_code": "89052-3107", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide.", "recall_number": "D-1004-2018", "product_description": "Gaia Kratom (mitragyna speciosa) powder,  Purple 8-1, 1oz, 250g, 1kg packages, Gaia Ethnobotanical.com", "product_quantity": "unknown", "reason_for_recall": "Microbal Contamination of Non-Sterile Product; FDA analysis found  salmonella contamination", "recall_initiation_date": "20180620", "center_classification_date": "20180726", "termination_date": "20220126", "report_date": "20180718", "code_info": "Lot # 0102031800", "more_code_info": ""}, {"country": "United States", "city": "Staten Island", "address_1": "119 Linwood Ave", "reason_for_recall": "Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.", "address_2": "", "product_quantity": "unknown", "code_info": "All Lots", "center_classification_date": "20180228", "distribution_pattern": "NY and NJ through six retail stores named \"Asian Food Markets\"", "state": "NY", "product_description": "GERMANY NIUBIAN tablets, 3000mg, 10-count bottle, labeling is in foreign language", "report_date": "20180207", "classification": "Class I", "openfda": {}, "recalling_firm": "A&H Focal Inc.", "recall_number": "D-0556-2018", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "76644", "termination_date": "20190614", "more_code_info": "", "recall_initiation_date": "20170307", "postal_code": "10305-4445", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "37 ml", "code_info": "All lots distributed between November 2014 and May 2015    03202015@1, 9/16/2015, 01192015@54, 7/18/2015; 04082015@4, 10/5/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Testosterone Cypionate 150 mg/ml Injection Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1641-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0366-2020", "product_description": "Equate Comfort Gel Lubricant Eye Gel Twin Pack W-M item #: 552374319, Package Size: 2 x 15 mL, Distributed by: Walmart Inc., Bentonville, AR 72716, NDC 49035-197-49", "product_quantity": "469128 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "Lot #: 17384, Exp 12/19; 17259, Exp 08/19; 19002, Exp 01/21; 19041, Exp 02/21; 18222, Exp 09/20; 18084, Exp 04/20"}, {"country": "United States", "city": "Noblesville", "address_1": "14450 Getz Rd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "384", "code_info": "All Sterile Compounded Products within Expiry", "center_classification_date": "20160711", "distribution_pattern": "Nationwide        VA/DOD: CA, KY, MD, NC, OK, TX, VA", "state": "IN", "product_description": "Oxytocin 30 Units added to 0.9% Sodium Chloride in a 500 mL lntravia bag, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0735-03", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Pharmakon Pharmaceuticals, Inc.", "recall_number": "D-1295-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73960", "termination_date": "20180111", "more_code_info": "", "recall_initiation_date": "20160420", "postal_code": "46060-3303", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "86 ml total volume", "code_info": "All lots distributed between November 2014 and May 2015;   04142015@73, 7/13/2015; 03162015@65, 6/14/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Morphine 40 mg/ml + Fentanyl 2,000 mcg/ml Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1603-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "70148", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-454-2015", "product_description": "St Lukes East Lees Summit (MO) Protein Bag,Trophamine 5g, Dextrose 10%, Additives: Calcium Gluconate 4.65mEq, compound vol: 250 ml, sterile injectable, Rx only, compounded drug, IV infusion bag packaged in a corrugated box, each container is lined with a polystyrene insert; CAPS, Allentown, PA.", "product_quantity": "6 bags", "reason_for_recall": "Non-Sterility: Out of specification results for the sterility test for microbial contamination.", "recall_initiation_date": "20141217", "center_classification_date": "20150408", "termination_date": "20150819", "report_date": "20150415", "code_info": "lot number 37-74520, Made on 15 DEC 2014, EXP 24 DEC 2014, CAPS Rx: 37-74520-0-6-R, Disp ID: 37-1124617"}, {"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "Suite 180", "product_quantity": "273 vials", "code_info": "Lot #: 20130212-A, Exp 5/12/2013; 20130122-E, Exp 4/22/2013; 20130212-D, Exp 5/12/2013", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "Dexpanthenol Injection, all strengths and all presentations including Dexpanthenol 250 mg/30 mL; Dexpanthenol 250 mg/mL 10 mL, 30 mL, 50 mL; and Dexpanthenol 250 mg/mL 10 mL P.F.; Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.", "report_date": "20130522", "classification": "Class II", "openfda": {}, "recalling_firm": "FVS Holdings, Inc. dba. Green Valley Drugs", "recall_number": "D-358-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "64879", "termination_date": "20140321", "more_code_info": "", "recall_initiation_date": "20130410", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0146-2019", "product_description": "Calcium Gluconate 1% Eyewash Oph. Soln, 10 mg/mL, 1000 mL bottles, Pharm D Solutions, Houston, Texas ---- NDC 69699-0907-10", "product_quantity": "25 bottles", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lots: 05072018:27 Discard by: 5/2/2019; 07122018:11 Discard by 7/7/2019"}, {"status": "Terminated", "city": "Saint Paul", "state": "MN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72886", "recalling_firm": "Fagron, Inc", "address_1": "2400 Pilot Knob Rd", "address_2": "N/A", "postal_code": "55120-1118", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0655-2016", "product_description": "SyrSpend SF, Suspending Base, Grape Flavored, a convenient, sweetened, sugar-free syrup-suspending vehicle specially formulated to assist in extemporaneous preparation of oral liquid dose forms, Rx Only, Shake Well, 4 L bottle, Manufactured by Fagron Inc., St. Paul, MN 55120, NDC 51552-1167-9.", "product_quantity": "148 Bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Syrspend SF and Syrspend SF Grape Flavor are being recalled due to the presence of yeast.", "recall_initiation_date": "20151111", "center_classification_date": "20160205", "termination_date": "20170822", "report_date": "20160217", "code_info": "Lot #s: 15A05-U03-022765; 15G29-U03-025975; 15A05-U06-023277", "more_code_info": ""}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0341-2017", "product_description": "Arginine/Citrulline/Ornit+Lido 100/100/100/10 mg/mL Injectable, 10 mL vials, Compounded by Wells Pharmacy Network, LLC, Ocala, FL", "product_quantity": "30 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known lot code: 06032016@7, 09092016@5"}, {"status": "Terminated", "city": "Hawthorne", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M005"], "brand_name": ["HEB"], "generic_name": ["CLOTRIMAZOLE"], "manufacturer_name": ["H E B"], "product_ndc": ["37808-305"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["CLOTRIMAZOLE"], "rxcui": ["309367"], "spl_id": ["39adf5d6-2001-9513-e063-6294a90a14c5"], "spl_set_id": ["8f07dc5a-cfa8-4a57-ac90-552a7c947cc5"], "package_ndc": ["37808-305-01"], "is_original_packager": [true], "nui": ["N0000175487", "M0002083"], "pharm_class_epc": ["Azole Antifungal [EPC]"], "pharm_class_cs": ["Azoles [CS]"], "unii": ["G07GZ97H65"]}, "product_type": "Drugs", "event_id": "86833", "recalling_firm": "Taro Pharmaceuticals U.S.A., Inc.", "address_1": "3 Skyline Dr", "address_2": "N/A", "postal_code": "10532-2174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA and Canada", "recall_number": "D-0152-2021", "product_description": "H-E-B - Athlete's Foot Cream Clotrimazole Cream USP, 1% Anitfungal NET WT. 0.5 oz. (14.2 g),  Made with Pride & Care for H-E-B San Antonio, TX 78204 Made in Canada NDC 37808-305-01", "product_quantity": "N/A", "reason_for_recall": "Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%.", "recall_initiation_date": "20201117", "center_classification_date": "20201216", "termination_date": "20240221", "report_date": "20201223", "code_info": "Lot#: A873630558 Dec-2020; D867331276, Exp Mar-2021"}, {"country": "United States", "city": "Lincoln", "address_1": "10401 Hwy 6", "reason_for_recall": "Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing.", "address_2": "", "product_quantity": "32,256/24-caplet packages", "code_info": "Lot # 10119267 exp 07/13  Lot # 10123857 exp 07/13  Lot # 10123888 exp 09/13", "center_classification_date": "20140116", "distribution_pattern": "Distribution was made nationwide and foriegn distribution was made--Mexicio, Panama, Ecuador and Venezuela.", "state": "NE", "product_description": "Maximum Strength Comtrex Nighttime Cold & Cough, Acetaminophen 325mg ,Chlorpheniramine Maleate 2mg,  Dextromethorphan HBR 10mg,Phenylephrine HCL 5mg,   packaged in 24 coated caplets nighttime formula *includes antihistamine, Distributed by: Novartis Consumer Health, Inc., Parsippany, NJ 075054-0622,  NDC 0067-2081-24.", "report_date": "20140122", "classification": "Class III", "openfda": {}, "recalling_firm": "Novartis Consumer Health", "recall_number": "D-739-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "65181", "termination_date": "20141104", "more_code_info": "", "recall_initiation_date": "20130515", "postal_code": "68517-9626", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Manvel", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78235", "recalling_firm": "Kiriko, LLC.", "address_1": "3522 Ewing Dr", "address_2": "N/A", "postal_code": "77578-3218", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide.", "recall_number": "D-0058-2018", "product_description": "A1 Slim, Dietary Supplement Beautifully Slim, capsule, 350 mg, 30-count bottle, A1 Slim LLC Pearland TX 77584,  www.A1SLIM.COM, info@a1slim.com Bar-Code A105212014", "product_quantity": "700 bottles", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared  sibutramine, phenolphthalein, and n-desmethyl sibutramine, making this an unapproved drug for which safety and efficacy have not been established and therefore, subject to recall.", "recall_initiation_date": "20171006", "center_classification_date": "20171101", "termination_date": "20200909", "report_date": "20171108", "code_info": "All lots remaining within expiry."}]